205 related articles for article (PubMed ID: 37270763)
1. Dupilumab-associated mycosis fungoides: a cross-sectional study.
Hamp A; Hanson J; Schwartz RA; Lambert WC; Alhatem A
Arch Dermatol Res; 2023 Nov; 315(9):2561-2569. PubMed ID: 37270763
[TBL] [Abstract][Full Text] [Related]
2. Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates.
Sokumbi O; Shamim H; Davis MDP; Wetter DA; Newman CC; Comfere N
Am J Dermatopathol; 2021 Oct; 43(10):714-720. PubMed ID: 34132660
[TBL] [Abstract][Full Text] [Related]
3. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis.
Boesjes CM; van der Gang LF; Bakker DS; Ten Cate TA; Spekhorst LS; de Graaf M; van Dijk MR; de Bruin-Weller MS
JAMA Dermatol; 2023 Nov; 159(11):1240-1247. PubMed ID: 37851456
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab-Associated Sezary Syndrome.
Hamp A; Hanson J; Alhatem A; Schwartz RA
Indian J Dermatol; 2023; 68(4):459-462. PubMed ID: 37822402
[TBL] [Abstract][Full Text] [Related]
6. Tumor stage mycosis fungoides in a patient treated with long-term corticosteroids for asthma and atopic-like dermatitis.
Abel EA; Nickoloff BJ; Shelby DM; Watson W; Wood GS
J Dermatol Surg Oncol; 1986 Oct; 12(10):1089-93. PubMed ID: 3489744
[TBL] [Abstract][Full Text] [Related]
7. Mycosis Fungoides Unmasked by Dupilumab Treatment in a Patient With a History of Atopic Dermatitis.
Ayasse M; Nelson K; Glass F; Silverberg JI
Dermatitis; 2021 Oct; 32(1S):e88-e89. PubMed ID: 33273230
[No Abstract] [Full Text] [Related]
8. Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome.
Hirotsu KE; Neal TM; Khodadoust MS; Wang JY; Rieger KE; Strelo J; Hong E; Kim YH; Kwong BY
JAMA Dermatol; 2021 Jun; 157(6):700-707. PubMed ID: 33881447
[TBL] [Abstract][Full Text] [Related]
9. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.
Lebowitz E; Geller S; Flores E; Pulitzer M; Horwitz S; Moskowitz A; Kheterpal M; Myskowski PL
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):108-114. PubMed ID: 30176169
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Mycosis Fungoides after Dupilumab Treatment for Atopic Dermatitis.
O'Neill L; Duffy RF; Manders SM
Skinmed; 2023; 21(2):105-106. PubMed ID: 37158349
[TBL] [Abstract][Full Text] [Related]
11. Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.
Anadolu RY; Birol A; Sanli H; Erdem C; Türsen U
Int J Dermatol; 2005 Jul; 44(7):559-65. PubMed ID: 15985024
[TBL] [Abstract][Full Text] [Related]
12. Nb-UVB and PUVA therapy in treating early stages of Mycosis Fungoides: A single-center cross-sectional study.
Zengarini C; Baruffaldi G; Piraccini BM; Bardazzi F; Mussi M; Hrvatin Stancic B; Pileri A
Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):435-440. PubMed ID: 36974002
[TBL] [Abstract][Full Text] [Related]
13. Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab.
Newsom M; Hrin ML; Hamid RN; Strowd LC; Ahn C; Jorizzo JL; Feldman SR
Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560800
[No Abstract] [Full Text] [Related]
14. Mycosis fungoides in young patients: clinical characteristics and outcome.
Crowley JJ; Nikko A; Varghese A; Hoppe RT; Kim YH
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):696-701. PubMed ID: 9591813
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptor serum levels in mycosis fungoides. Correlation with clinical stage.
Szeimies RM; Rueff F; Kaudewitz P
Cancer; 1992 Nov; 70(9):2338-41. PubMed ID: 1394062
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
18. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
Molloy K; Jonak C; Woei-A-Jin FJSH; Guenova E; Busschots AM; Bervoets A; Hauben E; Knobler R; Porkert S; Fassnacht C; Cowan R; Papadavid E; Beylot-Barry M; Berti E; Alberti Violetti S; Estrach T; Matin R; Akilov O; Vakeva L; Prince M; Bates A; Bayne M; Wachsmuch R; Wehkamp U; Marschalko M; Servitje O; Turner D; Weatherhead S; Wobser M; Sanches JA; McKay P; Klemke D; Peng C; Howles A; Yoo J; Evison F; Scarisbrick J
Br J Dermatol; 2020 Mar; 182(3):770-779. PubMed ID: 31049926
[TBL] [Abstract][Full Text] [Related]
19. Mycosis Fungoides and Its Relationship to Atopy, Serum Total IgE, and Eosinophil Counts.
Vonderheid EC; Hamilton RG; Kadin ME
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):279-288.e7. PubMed ID: 33342729
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]